The 34 countries that are supposed to be desirable travel destinations for industry stakeholders are covered by the report. The important players chosen for benchmarking and profiling are chosen based on their probable investment criteria, regional dominance, and global reach. The supply-side contribution of each local, regional, and international actor to the overall market has been taken into account.

Request for free broacher:

Antacid Market Overview:

In order to determine the total size of Antacid market by countries and segments, the report conducted a micro level analysis of each nation. The size of the regional and global markets is assessed using a bottom-up methodology. By doing a micro-level analysis of each country, it is possible to determine the contribution of the unorganized market to the overall market size. The Antacid market determine the extensive research for the business firm, and provide the latest drivers, restraints, and opportunities for Antacid market. The results are then verified through interviews with local business leaders. The secondary research and analysis of the same are done using both paid and unpaid data bases. Consumption in each country by kind and supply by each player are sourced from legitimate government databases, paid databases, and, in the case of listed firms, company annual reports. If a company's annual reports are not made public, they might be obtained from the tax department of the local government.

Antacid Market size was valued at USD 7 Bn. in 2021 and the total Antacid Market revenue is expected to grow at 4.5 % from 2022 to 2029, reaching nearly USD 9.9 Bn.

Antacids Market

Antacid Market Dynamics:

MMR Research is a targeted and practical research approach that makes it possible to examine the key Drugs market dynamics by both established and developing regions of the globe. Additionally, our experts undertake in-depth analyses of geographical areas to give clients and organisations the chance to excel in specialised industries and grow in developing global markets. This market research study also highlights the dynamically shifting Player landscape that affects the market's growth.

Antacids are used to counteract acidity, which results in a sharp growth in demand. But according to research done by the American Gastroenterological Association and released by the International Functional Foundation in February 2017, around one-third of Americans have GERD.

With the help of digital marketing initiatives and commercials, over-the-counter pharmaceuticals are becoming more and more popular, creating profitable growth potential for the antacids market. There are opportunities for the market to expand because of the rising prevalence of gastrointestinal issues being treated globally. The market's demand is driven by the growing elderly population since aged people are more likely to experience acidity issues. Numerous acidity-related issues are also brought on by adopting sedentary lifestyles. The market for antacids is developing along with the growing need for early diagnosis among people. Increased emphasis on producing high-quality pharmaceuticals and a high manufacturing rate have a big impact on market demand. The antacids market is expanding as a result of rising disposable income in metropolitan areas. Additionally, the rising popularity of self-medication is substantially accelerating this market's development pace. Growing consumer knowledge of the early signs of digestive disorders is also driving up antacid use.

Antacid Market Segment:

Based on Dosage Form, The Tablet segment is expected to grow at the highest CAGR during the forecast period. The market's availability of a range of chewable tablets in various tastes that aid in enhancing patient adherence to the prescription is expected to support the segment's growth. Additionally, tablets are convenient to keep and give patients the right dosage. These elements are responsible for the segment's growth during the forecast period. Since tablets are the cheapest oral dosage form and the easiest to handle, use, and carry, they are the most commonly utilized solid dose form. Additionally, as the senior population is more susceptible to gastrointestinal diseases, the growing geriatric population is expected to fuel market growth. In 2050, 1 in 7 persons worldwide may be beyond the age of 65 (17%), up from 1 in 11 in 2019 (10%), according to figures from the World Population Prospects, 2019 version.

To release innovative and trustworthy products on the market, the key industry players are also concentrating on research and development operations. For instance, Dr. Reddy's Laboratories brought generic chlordiazepoxide hydrochloride and clidinium bromide capsules for the treatment of stomach ulcers, irritable bowel syndrome, and colon inflammation to the American market in August 2021. Additionally, Dr. Reddy's laboratories introduced generic omeprazole delayed-release tablets in the US in January 2019 to treat heartburn. Additionally, product approval also helps the market expand. For instance, the United States Food and Drug Administration (FDA) in December 2021 approved glycopyrrolate orally disintegrating tablets (Dartisla ODT; Edenbridge Pharmaceuticals) to treat and decrease the symptoms of peptic ulcers. These approvals are expected to speed up market growth by introducing better products to the market. The aforementioned factors are expected to cause the market under study to grow significantly during the forecast period.

Request for Free sample Pages:

Regional Analysis:

On the basis of geography, the Antacid market is segmented into 5 main regions and they are- North America, Europe, Asia Pacific, the Middle East, Africa, and South America respectively.

Research methodology:

  • The size of the global Antacid market is estimated and validated using the top-down and bottom-up methodologies.
  • Different industry classification standards are strictly adhered to by players in order to reach an exhaustive list of functional and relevant players. A thorough validation test is also carried out in order to locate the most pertinent players for the survey in the Antacid market.
  • With the aid of paid databases like Factiva, Bloomberg, etc., priority lists are sorted depending on revenue generated based on most recent reporting.
  • Finally, the questionnaire was defined and specifically designed to meet all the needs of collecting primary data by prior appointment, targeting the main target groups, incl. This helps us collect data on player revenue, operating cycle and expenses, profit and product or service growth, among other things. Almost 70-80% of the data is collected through primary media and further validated through various secondary sources including regulators, World Bank, associations, company websites, SEC filings, OTC BB, USPTO, EPO, annual reports, press releases etc.

Speak with our research analyst:

Antacid Market Key players:

• Bayer AG

• Haleon

• Johnson & Johnson

• Sun Pharmaceuticals Ltd

• Sanofi S.A

• WellSpring Pharmaceutical Corporation

• Advance Pharmaceutical Inc.

• CVS Pharmacy

• Safetec of America, Inc.

• Pfizer inc.

• Boehringer Ingelheim International GmbH

• Dr. Reddy's Laboratories Ltd.

• Reckitt Benckiser Group plc.

Contact us:


3rd Floor, Navale IT Park Phase 2,

Pune Banglore Highway,

Narhe, Pune, Maharashtra 411041, India.

Get More Similar Link :